PT725655E - Utilizacao de compostos capazes de se ligar a glicoproteina gpiib/iiia para a prevencao de estenose e de restenose - Google Patents

Utilizacao de compostos capazes de se ligar a glicoproteina gpiib/iiia para a prevencao de estenose e de restenose

Info

Publication number
PT725655E
PT725655E PT95902460T PT95902460T PT725655E PT 725655 E PT725655 E PT 725655E PT 95902460 T PT95902460 T PT 95902460T PT 95902460 T PT95902460 T PT 95902460T PT 725655 E PT725655 E PT 725655E
Authority
PT
Portugal
Prior art keywords
immunoglobulins
stenosis
restenosis
gpiib
prevention
Prior art date
Application number
PT95902460T
Other languages
English (en)
Inventor
Barry S Coller
Harlan F Weisman
Original Assignee
Centocor Inc
Res Foundation Of State Univ N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22523494&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT725655(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centocor Inc, Res Foundation Of State Univ N filed Critical Centocor Inc
Publication of PT725655E publication Critical patent/PT725655E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT95902460T 1993-11-05 1994-11-07 Utilizacao de compostos capazes de se ligar a glicoproteina gpiib/iiia para a prevencao de estenose e de restenose PT725655E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14792893A 1993-11-05 1993-11-05

Publications (1)

Publication Number Publication Date
PT725655E true PT725655E (pt) 2004-01-30

Family

ID=22523494

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95902460T PT725655E (pt) 1993-11-05 1994-11-07 Utilizacao de compostos capazes de se ligar a glicoproteina gpiib/iiia para a prevencao de estenose e de restenose

Country Status (15)

Country Link
EP (2) EP1334730A3 (pt)
JP (1) JPH09504795A (pt)
CN (2) CN1140295C (pt)
AT (1) ATE247980T1 (pt)
AU (2) AU1172495A (pt)
CA (1) CA2175214A1 (pt)
DE (1) DE69433091T3 (pt)
DK (1) DK0725655T4 (pt)
ES (1) ES2204937T5 (pt)
HK (1) HK1054682B (pt)
NZ (2) NZ502819A (pt)
PT (1) PT725655E (pt)
RU (1) RU2158135C2 (pt)
UA (1) UA37249C2 (pt)
WO (1) WO1995012412A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
US5753230A (en) † 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
WO1996040250A2 (en) * 1995-06-07 1996-12-19 Centocor, Inc. Platelet-specific chimeric immunoglobulin and methods of use therefor
CA2282501A1 (en) * 1997-02-19 1998-08-27 Centocor, Inc. Sustained drug delivery and compositions useful therefor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1297815C (en) * 1985-06-07 1992-03-24 Barry S. Coller Fibrinogen blocking monoclonal antibody
CA1297816C (en) * 1985-06-14 1992-03-24 Barry S. Coller Platelet function inhibiting monoclonal antibody fragment
KR940009084B1 (ko) * 1988-05-18 1994-09-29 체크 포인트 시스템스, 인코오퍼레이티드 자기 및 공명회로 검출용 안테나 시스템
ATE124267T1 (de) * 1989-04-03 1995-07-15 Centocor Inc Blutplättchenspezifische immunokonjugate.
EP0606391B1 (en) * 1991-09-30 1998-08-05 Biogen, Inc. Inhibition of vascular narrowing using anti-padgem antibodies
WO1993013133A1 (en) * 1991-12-20 1993-07-08 Yamanouchi Pharmaceutical Co., Ltd. HUMAN TYPE ANTIBODY REACTIVE WITH GPIIb/IIIa

Also Published As

Publication number Publication date
AU8959398A (en) 1999-01-14
HK1054682B (zh) 2006-05-04
DE69433091T2 (de) 2004-06-03
CN1230201C (zh) 2005-12-07
WO1995012412A1 (en) 1995-05-11
EP1334730A3 (en) 2003-12-03
ES2204937T5 (es) 2009-07-06
CA2175214A1 (en) 1995-05-11
CN1140295C (zh) 2004-03-03
DE69433091T3 (de) 2009-07-30
RU2158135C2 (ru) 2000-10-27
EP1334730A2 (en) 2003-08-13
JPH09504795A (ja) 1997-05-13
DK0725655T4 (da) 2009-05-18
AU1172495A (en) 1995-05-23
NZ502819A (en) 2002-09-27
EP0725655B1 (en) 2003-08-27
EP0725655A1 (en) 1996-08-14
EP0725655B2 (en) 2009-04-15
UA37249C2 (uk) 2001-05-15
CN1142189A (zh) 1997-02-05
ATE247980T1 (de) 2003-09-15
DE69433091D1 (de) 2003-10-02
HK1054682A1 (en) 2003-12-12
DK0725655T3 (da) 2004-01-05
CN1404877A (zh) 2003-03-26
ES2204937T3 (es) 2004-05-01
NZ527820A (en) 2005-04-29

Similar Documents

Publication Publication Date Title
DE68929380T2 (de) Plättchen-spezifisches chimärisches immunglobulin
WO2003072036A3 (en) Treatment methods using anti-cd22 antibodies
EP0673255A4 (en) MONOCLONAL ANTIBODY, WHICH SPECIFICALLY BINDS TO VASCULARIZED TUMOR DOTHELIUM AND USES THEREOF.
MY113497A (en) Peptides and compounds that bind to a receptor
ATE168013T1 (de) Humanisierte chimäre anti-''icam-1'' antikörper, herstellungsverfahren und verwendung
NZ511956A (en) Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
WO1997046589A3 (en) Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
NL300220I1 (nl) Immunoglobuline varianten voor specifieke FC-epsilon receptoren.
AU7689496A (en) Design of hormone-like antibodies with agonistic and antagonistic functions
TR200301846T2 (tr) Cripto bloke edici Antikorlar ve bu antikorların kullanımları.
GR3035617T3 (en) Methods and compositions for the specific coagulation of vasculature
ATE429450T1 (de) Chimärische dr4 antikörper und ihre verwendung
CA2093928A1 (en) Monoclonal antibodies for detection and treatment of cancer
AU8555291A (en) Delivery of agents
PT725655E (pt) Utilizacao de compostos capazes de se ligar a glicoproteina gpiib/iiia para a prevencao de estenose e de restenose
AU1125192A (en) Fusion proteins for prodrug activation, the preparation and use thereof
CA2126182A1 (en) Humanized antibodies reactive with gpiib/iiia
WO1996040250A3 (en) Platelet-specific chimeric immunoglobulin and methods of use therefor
DE69020548T2 (de) Blutplättchenspezifische immunokonjugate.
DE59601383D1 (de) Zweibandagige bodenverdichtungsvorrichtung und deren lenkung
AU3283693A (en) Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy
GB9715177D0 (en) Medicament
GR3036968T3 (en) Adamantyl substituted oxindoles as pharmaceutical agents
IT232926Y1 (it) contenitore di sicurezza per aghi medicali gia' utilizzati, in particolare per aghi farfalla.